肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

梅斯作为媒体参与第二届东方肿瘤分子诊断与靶向治疗学术会议

2016-11-14 MedSci MedSci原创

钦伦秀梅斯
关注















版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1809058, encodeId=0a3e180905826, content=<a href='/topic/show?id=7bbc8283617' target=_blank style='color:#2F92EE;'>#肿瘤分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82836, encryptionId=7bbc8283617, topicName=肿瘤分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Mon Apr 24 02:20:00 CST 2017, time=2017-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904683, encodeId=2611190468330, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 09 14:20:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078077, encodeId=3b8f20e80772c, content=<a href='/topic/show?id=eadf82828a1' target=_blank style='color:#2F92EE;'>#肿瘤分子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82828, encryptionId=eadf82828a1, topicName=肿瘤分子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat May 06 21:20:00 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276907, encodeId=545b12e690736, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622907, encodeId=2e53162290ee7, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=)]
    2017-04-24 旅苦化文_208

    #肿瘤分子诊断#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1809058, encodeId=0a3e180905826, content=<a href='/topic/show?id=7bbc8283617' target=_blank style='color:#2F92EE;'>#肿瘤分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82836, encryptionId=7bbc8283617, topicName=肿瘤分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Mon Apr 24 02:20:00 CST 2017, time=2017-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904683, encodeId=2611190468330, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 09 14:20:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078077, encodeId=3b8f20e80772c, content=<a href='/topic/show?id=eadf82828a1' target=_blank style='color:#2F92EE;'>#肿瘤分子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82828, encryptionId=eadf82828a1, topicName=肿瘤分子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat May 06 21:20:00 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276907, encodeId=545b12e690736, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622907, encodeId=2e53162290ee7, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=)]
    2017-06-09 axin009

    #学术会议#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1809058, encodeId=0a3e180905826, content=<a href='/topic/show?id=7bbc8283617' target=_blank style='color:#2F92EE;'>#肿瘤分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82836, encryptionId=7bbc8283617, topicName=肿瘤分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Mon Apr 24 02:20:00 CST 2017, time=2017-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904683, encodeId=2611190468330, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 09 14:20:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078077, encodeId=3b8f20e80772c, content=<a href='/topic/show?id=eadf82828a1' target=_blank style='color:#2F92EE;'>#肿瘤分子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82828, encryptionId=eadf82828a1, topicName=肿瘤分子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat May 06 21:20:00 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276907, encodeId=545b12e690736, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622907, encodeId=2e53162290ee7, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=)]
    2017-05-06 howi

    #肿瘤分子#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1809058, encodeId=0a3e180905826, content=<a href='/topic/show?id=7bbc8283617' target=_blank style='color:#2F92EE;'>#肿瘤分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82836, encryptionId=7bbc8283617, topicName=肿瘤分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Mon Apr 24 02:20:00 CST 2017, time=2017-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904683, encodeId=2611190468330, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 09 14:20:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078077, encodeId=3b8f20e80772c, content=<a href='/topic/show?id=eadf82828a1' target=_blank style='color:#2F92EE;'>#肿瘤分子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82828, encryptionId=eadf82828a1, topicName=肿瘤分子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat May 06 21:20:00 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276907, encodeId=545b12e690736, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622907, encodeId=2e53162290ee7, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=)]
    2016-11-16 一闲

    #梅斯#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1809058, encodeId=0a3e180905826, content=<a href='/topic/show?id=7bbc8283617' target=_blank style='color:#2F92EE;'>#肿瘤分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82836, encryptionId=7bbc8283617, topicName=肿瘤分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Mon Apr 24 02:20:00 CST 2017, time=2017-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904683, encodeId=2611190468330, content=<a href='/topic/show?id=85fa455346c' target=_blank style='color:#2F92EE;'>#学术会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45534, encryptionId=85fa455346c, topicName=学术会议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Jun 09 14:20:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078077, encodeId=3b8f20e80772c, content=<a href='/topic/show?id=eadf82828a1' target=_blank style='color:#2F92EE;'>#肿瘤分子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82828, encryptionId=eadf82828a1, topicName=肿瘤分子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat May 06 21:20:00 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276907, encodeId=545b12e690736, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622907, encodeId=2e53162290ee7, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Nov 16 05:20:00 CST 2016, time=2016-11-16, status=1, ipAttribution=)]
    2016-11-16 爆笑小医

    #分子诊断#

    0